Clinical outcomes in stage III non-small cell lung cancer patients treated with durvalumab after sequential or concurrent platinum-based chemoradiotherapy – single institute experience

Catégorie d'article: Research Article

Publié en ligne: 19 nov. 2021

Pages: 482 - 490

Reçu: 19 août 2021

Accepté: 07 oct. 2021

DOI: https://doi.org/10.2478/raon-2021-0044

Mots clés

non-small cell lung cancer, stage III, chemoradiotherapy, durvalumab

© 2021 Martina Vrankar, Karmen Stanic, Stasa Jelercic, Eva Ciric, Ana Lina Vodusek, Jasna But-Hadzic, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.